279 related articles for article (PubMed ID: 35917865)
1. Engineered ionizable lipid siRNA conjugates enhance endosomal escape but induce toxicity in vivo.
Biscans A; Ly S; McHugh N; Cooper DA; Khvorova A
J Control Release; 2022 Sep; 349():831-843. PubMed ID: 35917865
[TBL] [Abstract][Full Text] [Related]
2.
Algarni A; Pilkington EH; Suys EJA; Al-Wassiti H; Pouton CW; Truong NP
Biomater Sci; 2022 May; 10(11):2940-2952. PubMed ID: 35475455
[TBL] [Abstract][Full Text] [Related]
3. Comparison of DLin-MC3-DMA and ALC-0315 for siRNA Delivery to Hepatocytes and Hepatic Stellate Cells.
Ferraresso F; Strilchuk AW; Juang LJ; Poole LG; Luyendyk JP; Kastrup CJ
Mol Pharm; 2022 Jul; 19(7):2175-2182. PubMed ID: 35642083
[TBL] [Abstract][Full Text] [Related]
4. The valency of fatty acid conjugates impacts siRNA pharmacokinetics, distribution, and efficacy in vivo.
Biscans A; Coles A; Echeverria D; Khvorova A
J Control Release; 2019 May; 302():116-125. PubMed ID: 30940496
[TBL] [Abstract][Full Text] [Related]
5. Unsaturated, Trialkyl Ionizable Lipids are Versatile Lipid-Nanoparticle Components for Therapeutic and Vaccine Applications.
Lam K; Leung A; Martin A; Wood M; Schreiner P; Palmer L; Daly O; Zhao W; McClintock K; Heyes J
Adv Mater; 2023 Apr; 35(15):e2209624. PubMed ID: 36680477
[TBL] [Abstract][Full Text] [Related]
6. pH-dependent structural transitions in cationic ionizable lipid mesophases are critical for lipid nanoparticle function.
Philipp J; Dabkowska A; Reiser A; Frank K; Krzysztoń R; Brummer C; Nickel B; Blanchet CE; Sudarsan A; Ibrahim M; Johansson S; Skantze P; Skantze U; Östman S; Johansson M; Henderson N; Elvevold K; Smedsrød B; Schwierz N; Lindfors L; Rädler JO
Proc Natl Acad Sci U S A; 2023 Dec; 120(50):e2310491120. PubMed ID: 38055742
[TBL] [Abstract][Full Text] [Related]
7. Imidazolyl Lipids Enhanced LNP Endosomal Escape for Ferroptosis RNAi Treatment of Cancer.
Liu Y; He F; Chen L; Zhang Y; Zhang H; Xiao J; Meng Q
Small; 2024 Jun; ():e2402362. PubMed ID: 38829038
[TBL] [Abstract][Full Text] [Related]
8. Flash nanoprecipitation assisted self-assembly of ionizable lipid nanoparticles for nucleic acid delivery.
Misra B; Hughes KA; Pentz WH; Samart P; Geldenhuys WJ; Bobbala S
Nanoscale; 2024 Apr; 16(14):6939-6948. PubMed ID: 38511623
[TBL] [Abstract][Full Text] [Related]
9. The chemical structure and phosphorothioate content of hydrophobically modified siRNAs impact extrahepatic distribution and efficacy.
Biscans A; Caiazzi J; Davis S; McHugh N; Sousa J; Khvorova A
Nucleic Acids Res; 2020 Aug; 48(14):7665-7680. PubMed ID: 32672813
[TBL] [Abstract][Full Text] [Related]
10. DOPC
Ermilova I; Swenson J
Phys Chem Chem Phys; 2020 Dec; 22(48):28256-28268. PubMed ID: 33295352
[TBL] [Abstract][Full Text] [Related]
11. Interaction of cholesterol-conjugated ionizable amino lipids with biomembranes: lipid polymorphism, structure-activity relationship, and implications for siRNA delivery.
Zhang J; Fan H; Levorse DA; Crocker LS
Langmuir; 2011 Aug; 27(15):9473-83. PubMed ID: 21648950
[TBL] [Abstract][Full Text] [Related]
12. Influence of cationic lipid composition on gene silencing properties of lipid nanoparticle formulations of siRNA in antigen-presenting cells.
Basha G; Novobrantseva TI; Rosin N; Tam YY; Hafez IM; Wong MK; Sugo T; Ruda VM; Qin J; Klebanov B; Ciufolini M; Akinc A; Tam YK; Hope MJ; Cullis PR
Mol Ther; 2011 Dec; 19(12):2186-200. PubMed ID: 21971424
[TBL] [Abstract][Full Text] [Related]
13. Ionizable amino lipid interactions with POPC: implications for lipid nanoparticle function.
Ramezanpour M; Schmidt ML; Bodnariuc I; Kulkarni JA; Leung SSW; Cullis PR; Thewalt JL; Tieleman DP
Nanoscale; 2019 Aug; 11(30):14141-14146. PubMed ID: 31334542
[TBL] [Abstract][Full Text] [Related]
14. Understanding structure-activity relationships of pH-sensitive cationic lipids facilitates the rational identification of promising lipid nanoparticles for delivering siRNAs in vivo.
Sato Y; Hashiba K; Sasaki K; Maeki M; Tokeshi M; Harashima H
J Control Release; 2019 Feb; 295():140-152. PubMed ID: 30610950
[TBL] [Abstract][Full Text] [Related]
15. Diverse lipid conjugates for functional extra-hepatic siRNA delivery in vivo.
Biscans A; Coles A; Haraszti R; Echeverria D; Hassler M; Osborn M; Khvorova A
Nucleic Acids Res; 2019 Feb; 47(3):1082-1096. PubMed ID: 30544191
[TBL] [Abstract][Full Text] [Related]
16. Lipid shape and packing are key for optimal design of pH-sensitive mRNA lipid nanoparticles.
Tesei G; Hsiao YW; Dabkowska A; Grönberg G; Yanez Arteta M; Ulkoski D; Bray DJ; Trulsson M; Ulander J; Lund M; Lindfors L
Proc Natl Acad Sci U S A; 2024 Jan; 121(2):e2311700120. PubMed ID: 38175863
[TBL] [Abstract][Full Text] [Related]
17. CHARMM-GUI Membrane Builder for Lipid Nanoparticles with Ionizable Cationic Lipids and PEGylated Lipids.
Park S; Choi YK; Kim S; Lee J; Im W
J Chem Inf Model; 2021 Oct; 61(10):5192-5202. PubMed ID: 34546048
[TBL] [Abstract][Full Text] [Related]
18. Light-Activated siRNA Endosomal Release (LASER) by Porphyrin Lipid Nanoparticles.
Mo Y; Cheng MHY; D'Elia A; Doran K; Ding L; Chen J; Cullis PR; Zheng G
ACS Nano; 2023 Mar; 17(5):4688-4703. PubMed ID: 36853331
[TBL] [Abstract][Full Text] [Related]
19. Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics.
Kulkarni JA; Witzigmann D; Chen S; Cullis PR; van der Meel R
Acc Chem Res; 2019 Sep; 52(9):2435-2444. PubMed ID: 31397996
[TBL] [Abstract][Full Text] [Related]
20. Engineered ionizable lipid nanoparticles mediated efficient siRNA delivery to macrophages for anti-inflammatory treatment of acute liver injury.
Zhang H; Ding F; Zhu Z; Sun Q; Yang C
Int J Pharm; 2023 Jan; 631():122489. PubMed ID: 36521639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
